EUVIMEDEUVIMED entdecken
BeobachtungsstudieOpen Access · CC BY 4.0

Fecal Myeloperoxidase Levels Reflect Disease Activity in Children With Crohn’s Disease

Teagan S Edwards iD, Shaun S C Ho, Stephanie C Brown, Laura Appleton, Briana R Smith, Grace M Borichevsky, Akhilesh Swaminathan iD, Christopher M A Frampton, Richard B Gearry, Anthony J Kettle, Andrew S Day

Inflammatory Bowel Diseases · 2025

DOI: 10.1093/ibd/izae262 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Inflammatory Bowel Diseases, 2025. Verfasst von Teagan S Edwards und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Paediatrics, University of Otago, Christchurch, New Zealand. Hauptthemen laut MEDLINE: Peroxidase, Crohn Disease, Feces, Biomarkers. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: University of Otago, Cure Kids.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Crohn’s disease (CD) is a major form of inflammatory bowel disease (IBD) which has relapsing and remitting symptoms. Better ways to detect and monitor active disease are required for early diagnosis and optimal outcomes. We assessed fecal myeloperoxidase (fMPO), a neutrophil-derived enzyme that produces hypochlorous acid, as a marker of disease activity in children with CD.

Methods

This observational study assessed myeloperoxidase (MPO) levels in fecal samples from children aged <17 years with CD (51 with active or 42 inactive disease) measured by enzyme-linked immunosorbent assay (ELISA) and compared to controls (35 healthy siblings and 15 unrelated well children). Results were correlated with fecal calprotectin, serum C-reactive protein, urinary glutathione sulfonamide (a biomarker of hypochlorous acid), and disease activity scores. Differences between groups were assessed by analysis of variance. Receiver-operating-characteristic curves were used to assess how biomarkers predicted disease and disease activity.

Results

Fecal myeloperoxidase activity and fMPO protein correlated with fecal calprotectin (r = 0.78, P < .0001, and r = 0.81, P < .0001, respectively). Fecal myeloperoxidase activity and protein levels were significantly higher (P ≤ .0001) in individuals with active disease compared to healthy sibling controls, unrelated well children, and those with inactive disease. A 9.7 µg/g fMPO protein cutoff distinguished inactive from active disease (sensitivity = 75%, specificity = 76%). Urinary GSA was elevated in children with active disease (P < .0001) and correlated with fMPO protein (r = 0.43, P = .0002) in a subset of 72 children with IBD and controls.

Conclusions

Fecal myeloperoxidase may be superior to fCal at reflecting disease severity in children with CD and produces the damaging oxidant hypochlorous acid during active inflammation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PeroxidaseCrohn DiseaseFecesBiomarkersHumansFemaleMaleChildAdolescentLeukocyte L1 Antigen ComplexCase-Control StudiesSeverity of Illness IndexChild, PreschoolROC CurveC-Reactive ProteinEnzyme-Linked Immunosorbent Assay

Stichwörter der Autor:innen

biomarkersmyeloperoxidasepediatrics

Substanzen

PeroxidaseBiomarkersLeukocyte L1 Antigen ComplexMPO protein, humanC-Reactive Protein

Autor:innen und Institutionen

  • Department of Paediatrics, University of Otago, Christchurch, New Zealand.
  • Department of Gastroenterology and Clinical Nutrition, The Royal Children's Hospital Melbourne, Melbourne, Victoria, Australia.
  • Department of Paediatrics, University of Melbourne, Melbourne, Victoria, Australia.
  • Murdoch Children's Research Institute, Melbourne, Victoria, Australia.
  • Department of Pathology and Biomedical Sciences, Mātai Hāora-Centre for Redox Biology and Medicine, University of Otago, Christchurch, New Zealand.
  • Department of Medicine, University of Otago, Christchurch, New Zealand.

ORCID-Profile: Teagan S Edwards, Akhilesh Swaminathan

Förderung

  • University of Otago
  • Cure Kids

Zitieren

APA

Edwards, T. S., Ho, S. S. C., Brown, S. C., Appleton, L., Smith, B. R., Borichevsky, G. M., Swaminathan, A., Frampton, C. M. A., Gearry, R. B., Kettle, A. J., & Day, A. S. (2025). Fecal Myeloperoxidase Levels Reflect Disease Activity in Children With Crohn’s Disease. Inflammatory Bowel Diseases. https://doi.org/10.1093/ibd/izae262

Vancouver

Edwards TS, Ho SSC, Brown SC, Appleton L, Smith BR, Borichevsky GM, et al. Fecal Myeloperoxidase Levels Reflect Disease Activity in Children With Crohn’s Disease. Inflammatory Bowel Diseases. 2025. doi:10.1093/ibd/izae262

BibTeX
@article{Edwards2025,
  author = {Edwards, Teagan S and Ho, Shaun S C and Brown, Stephanie C and Appleton, Laura and Smith, Briana R and Borichevsky, Grace M and Swaminathan, Akhilesh and Frampton, Christopher M A and Gearry, Richard B and Kettle, Anthony J and Day, Andrew S},
  title = {Fecal Myeloperoxidase Levels Reflect Disease Activity in Children With Crohn’s Disease},
  journal = {Inflammatory Bowel Diseases},
  year = {2025},
  doi = {10.1093/ibd/izae262}
}
Kostenlos starten →